STUDY OBJECTIVES: To examine the impact of gender in narcoleptic patients on timeliness of diagnosis, symptomology, and health and lifestyle impairment. METHODS: This is a cross-sectional study of 109 consecutive patients (68 women) with newly diagnosed narcolepsy with and without cataplexy, from a University sleep disorders center. Consecutive patients were administered an 8-page questionnaire at the time of their diagnosis regarding sleep habits, medications, and medical conditions, lifestyle impairments, as well as details regarding narcolepsy-related symptoms. RESULTS: Men and women presented with remarkably similar narcolepsy related symptoms, yet women were more likely to be delayed in diagnosis; 85% of men were likely to be diagnosed by 16 years after symptom onset, compared to 28 years in women. More women were likely to remain undiagnosed at any given time point after symptom onset (hazard ratio for diagnosis of men compared to women 1.53; 95% CI 1.01-2.32; p = 0.04). Men and women reported similar degree of subjective sleepiness as measured by the Epworth Sleepiness Scale (mean 16.2 ± 4.5; p = 0.18), though women demonstrated significantly more severe objective sleepiness on multiple sleep latency testing (MSLT) (mean sleep latency in women = 5.4 min (± 4.1), in men 7.4 min (± 3.5); p = 0.03). Despite being more objectively sleepy, women were less likely to report lifestyle impairments in the areas of personal relationships (71% men, 44% women, p = 0.01) and physical activity (36% men, 16% women, p = 0.02), but were also more likely to self-medicate with caffeine (63.4% men, 82.4% women; p = 0.03). CONCLUSIONS: Narcolepsy impacts men and women's health and lifestyle differently, and may cause delays diagnosis for women.
STUDY OBJECTIVES: To examine the impact of gender in narcolepticpatients on timeliness of diagnosis, symptomology, and health and lifestyle impairment. METHODS: This is a cross-sectional study of 109 consecutive patients (68 women) with newly diagnosed narcolepsy with and without cataplexy, from a University sleep disorders center. Consecutive patients were administered an 8-page questionnaire at the time of their diagnosis regarding sleep habits, medications, and medical conditions, lifestyle impairments, as well as details regarding narcolepsy-related symptoms. RESULTS:Men and women presented with remarkably similar narcolepsy related symptoms, yet women were more likely to be delayed in diagnosis; 85% of men were likely to be diagnosed by 16 years after symptom onset, compared to 28 years in women. More women were likely to remain undiagnosed at any given time point after symptom onset (hazard ratio for diagnosis of men compared to women 1.53; 95% CI 1.01-2.32; p = 0.04). Men and women reported similar degree of subjective sleepiness as measured by the Epworth Sleepiness Scale (mean 16.2 ± 4.5; p = 0.18), though women demonstrated significantly more severe objective sleepiness on multiple sleep latency testing (MSLT) (mean sleep latency in women = 5.4 min (± 4.1), in men 7.4 min (± 3.5); p = 0.03). Despite being more objectively sleepy, women were less likely to report lifestyle impairments in the areas of personal relationships (71% men, 44% women, p = 0.01) and physical activity (36% men, 16% women, p = 0.02), but were also more likely to self-medicate with caffeine (63.4% men, 82.4% women; p = 0.03). CONCLUSIONS: Narcolepsy impacts men and women's health and lifestyle differently, and may cause delays diagnosis for women.
Entities:
Keywords:
Narcolepsy; diagnosis; gender; hypersomnia; sex; sleep; women
Authors: E O Bixler; A N Vgontzas; H M Lin; T Ten Have; J Rein; A Vela-Bueno; A Kales Journal: Am J Respir Crit Care Med Date: 2001-03 Impact factor: 21.405
Authors: J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai Journal: Neuron Date: 2001-05 Impact factor: 17.173
Authors: C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot Journal: Nat Med Date: 2000-09 Impact factor: 53.440
Authors: Barbara A Phillips; Nancy A Collop; Christopher Drake; Flavia Consens; Alexandros N Vgontzas; Terri E Weaver Journal: J Womens Health (Larchmt) Date: 2008-09 Impact factor: 2.681
Authors: T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel Journal: Neuron Date: 2000-09 Impact factor: 17.173
Authors: Noeen Sarfraz; David Okuampa; Hannah Hansen; Mark Alvarez; Elyse M Cornett; Juyeon Kakazu; Adam M Kaye; Alan D Kaye Journal: Health Psychol Res Date: 2022-05-30
Authors: Zhongxing Zhang; Yves Dauvilliers; Giuseppe Plazzi; Geert Mayer; Gert Jan Lammers; Joan Santamaria; Markku Partinen; Sebastiaan Overeem; Rafael Del Rio Villegas; Karel Sonka; Rosa Peraita-Adrados; Raphaël Heinzer; Aleksandra Wierzbicka; Birgit Högl; Mauro Manconi; Eva Feketeova; Antonio Martins da Silva; Jitka Bušková; Claudio L A Bassetti; Lucie Barateau; Fabio Pizza; Elena Antelmi; Jari K Gool; Rolf Fronczek; Carles Gaig; Ramin Khatami Journal: Nat Sci Sleep Date: 2022-05-31
Authors: Jari K Gool; Zhongxing Zhang; Martijn S S L Oei; Stephanie Mathias; Yves Dauvilliers; Geert Mayer; Giuseppe Plazzi; Rafael Del Rio-Villegas; Joan Santamaria Cano; Karel Šonka; Markku Partinen; Sebastiaan Overeem; Rosa Peraita-Adrados; Raphael Heinzer; Antonio Martins da Silva; Birgit Högl; Aleksandra Wierzbicka; Anna Heidbreder; Eva Feketeova; Mauro Manconi; Jitka Bušková; Francesca Canellas; Claudio L Bassetti; Lucie Barateau; Fabio Pizza; Markus H Schmidt; Rolf Fronczek; Ramin Khatami; Gert Jan Lammers Journal: Neurology Date: 2022-04-18 Impact factor: 11.800
Authors: Madhukar Trivedi; Sapna Erat Sreedharan; Shana N Nair; C A Anees; J P Unnikrishnan; P S Sarma; Ashalatha Radhakrishnan Journal: Ann Indian Acad Neurol Date: 2019-10-25 Impact factor: 1.383
Authors: Maaike E Straat; Mink S Schinkelshoek; Rolf Fronczek; Gerrit Jan Lammers; Patrick C N Rensen; Mariëtte R Boon Journal: Front Endocrinol (Lausanne) Date: 2020-04-16 Impact factor: 5.555